Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1953 Mar;32(3):193–201. doi: 10.1172/JCI102727

A SPECIFIC INHIBITOR FOR HUMAN DESOXYRIBONUCLEASE AND AN INHIBITOR OF THE LUPUS ERYTHEMATOSUS CELL PHENOMENON FROM LEUCOCYTES 1

Nathaniel B Kurnick 1,2, Lawrence I Schwartz 1,2, Sanford Pariser 1,2,2, Stanley L Lee 1,2
PMCID: PMC438328  PMID: 13044827

Full text

PDF
193

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERMAN L., AXELROD A. R., GOODMAN H. L., McCLAUGHRY R. I. So-called "lupus erythematosus inclusion phenomenon" of bone marrow and blood. Am J Clin Pathol. 1950 May;20(5):403–418. doi: 10.1093/ajcp/20.5.403. [DOI] [PubMed] [Google Scholar]
  2. BERNHEIMER A. W., RUFFIER N. K. Elaboration of desoxyribonuclease by streptococci in the resting state and inhibition of the enzyme by a substance extractable from the cocci. J Exp Med. 1951 Apr 1;93(4):399–413. doi: 10.1084/jem.93.4.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BROWN K. D., JACOBS G., LASKOWSKI M. The distribution of nucleode polymerases it calf thymus fractions. J Biol Chem. 1952 Jan;194(1):445–454. [PubMed] [Google Scholar]
  4. HASERICK J. R., LEWIS L. A., BORTZ D. W. Blood factor in acute disseminated lupus erythematosus; determination of gamma globulin as specific plasma fraction. Am J Med Sci. 1950 Jun;219(6):660–663. doi: 10.1097/00000441-195006000-00010. [DOI] [PubMed] [Google Scholar]
  5. HENSTELL H. H., FREEDMAN R. I., GINSBURG B. An inhibitor of desoxyribonuclease in human white blood and bone marrow cells, and its relationship to cellular maturity. Cancer Res. 1952 May;12(5):346–349. [PubMed] [Google Scholar]
  6. HENSTELL H. H., FREEDMAN R. I. The viscosimetric determination of desoxyribonuclease inhibition. Cancer Res. 1952 May;12(5):341–345. [PubMed] [Google Scholar]
  7. KURNICK N. B., PARISER S., SCHWARTZ L. I., LEE S. L., IRVINE W. Studies on desoxyribonuclease in systemic lupus erythematosus; non-participation of serum desoxyribonuclease in the L.E. phenomenon. J Clin Invest. 1952 Dec;31(12):1036–1041. doi: 10.1172/JCI102696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. KURNICK N. B. The determination of desoxyribonuclease activity by methyl green; application to serum. Arch Biochem. 1950 Nov;29(1):41–53. [PubMed] [Google Scholar]
  9. Kunitz M. Isolation of Crystalline Desoxyribonuclease From Beef Pancreas. Science. 1948 Jul 2;108(2792):19–20. doi: 10.1126/science.108.2792.19-a. [DOI] [PubMed] [Google Scholar]
  10. LEE S. L., MICHAEL S. R., VURAL I. L. The L.E. (lupus erythematosus) cell; clinical and chemical studies. Am J Med. 1951 Apr;10(4):446–451. doi: 10.1016/0002-9343(51)90289-6. [DOI] [PubMed] [Google Scholar]
  11. MAVER M. E., GRECO A. E. The nuclease activities of cathepsin preparations from calf spleen and thymus. J Biol Chem. 1949 Dec;181(2):861–870. [PubMed] [Google Scholar]
  12. ROHN R. J., BOND W. H. Some supravital observations on the L.E. phenomenon. Am J Med. 1952 Apr;12(4):422–432. doi: 10.1016/0002-9343(52)90223-4. [DOI] [PubMed] [Google Scholar]
  13. WEBB M. Use of deoxyribonuclease inhibitors in the isolation of deoxyribonucleic acids. Nature. 1952 Mar 8;169(4297):417–417. doi: 10.1038/169417a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES